Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.
Press releases published on May 14, 2025
Jakub Leps Promoted to General Manager of Newsmatics Data Sciences
EIN Presswire
·
May 14, 2025
Leps to lead strategy and operations at the forefront of data innovation WASHINGTON, DC, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- Newsmatics, a news technology company known for its suite of innovative digital media products, is proud to …
غرينبيس الشرق الأوسط وشمال أفريقيا ومبادرة التمويل الأخلاقي العالمية تنظمان دورة عمل التمويل الإسلامي المستدام في دبي
EIN Presswire
·
May 14, 2025
دبي, UNITED ARAB EMIRATES, May 14, 2025 /EINPresswire.com/ -- استضافت مبادرة التمويل الأخلاقي العالمية بالشراكة مع غرينبيس الشرق الأوسط وشمال أفريقيا في إطار تحالف أمّة لأجل الأرض، دورة عمل التمويل الإسلامي المستدام. وجمعت الفعالية التي امتدت على مدى …
Results of Voting for Directors at Annual and Special Shareholders' Meeting
GlobeNewswire
·
May 14, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) announces the results of the vote on directors at the Annual and …
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 14, 2025
Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS); data readout expected in early 2026 $151.3 million in cash, cash equivalents, and short-term investments supports projected operations into 2027 SAN …
Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15
GlobeNewswire
·
May 14, 2025
SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has engaged Veloxity …
Codexis Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
Secured first revenue-generating contract for ECO Synthesis™ manufacturing services Company reiterates full-year financial guidance Six presentations to feature the ECO Synthesis platform at upcoming TIDES USA annual meeting, including three from leading …
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
GlobeNewswire
·
May 14, 2025
BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 14, 2025
PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee …
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
GlobeNewswire
·
May 14, 2025
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …
Speak Up Africa galvanizes private sector engagement to accelerate malaria-elimination efforts in Africa
EIN Presswire
·
May 14, 2025
The Change the Story campaign and report amplifies the voices of women and girls and mobilizes the African private sector to accelerate malaria elimination. ABIDJAN, IVORY COAST, May 14, 2025 /EINPresswire.com/ -- On the sidelines of the Africa CEO …
Robex Kiniero-Projekt auf Kurs für erste Goldförderung im vierten Quartal
GlobeNewswire
·
May 14, 2025
WESENTLICHE ASPEKTE: Die Bauarbeiten am Kiniero-Goldprojekt von Robex in Guinea verlaufen weiterhin planmäßig und im Rahmen des Budgets – die erste Goldproduktion ist für das vierte Quartal des Kalenderjahres 2025 vorgesehen. Das Projekt bleibt weiterhin …
Le projet Kiniero de Robex en bonne voie pour une première coulée d’or au quatrième trimestre
GlobeNewswire
·
May 14, 2025
FAITS MARQUANTS : La construction du projet aurifère Kiniero de Robex, en Guinée, suit le calendrier et le budget prévus. La première coulée d’or est prévue pour le quatrième trimestre de l’année civile 2025. Aucun accident du travail n’a été signalé à ce …
BURN SECURES US$5 MILLION INVESTMENT FROM ELECTRIFI TO SCALE ELECTRIC COOKING IN KENYA
EIN Presswire
·
May 14, 2025
BURN secures $5M from ElectriFI to deploy 100,000 ECOA electric stoves in Kenya, cutting fuel costs …
Critical One Discovers High-Grade Antimony Intervals in Howells Lake Project Historical Data
GlobeNewswire
·
May 14, 2025
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that the Company has discovered significant antimony, …
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
GlobeNewswire
·
May 14, 2025
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s PK …
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
GlobeNewswire
·
May 14, 2025
Salt Lake City, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that …
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
GlobeNewswire
·
May 14, 2025
Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations Early dose-escalation data from Phase 1 CARDINAL study of TERN-701 in CML patients showed …
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
GlobeNewswire
·
May 14, 2025
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, …
Robex Kiniero Project on Track for First Gold in Q4
GlobeNewswire
·
May 14, 2025
HIGHLIGHTS: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget - first gold pour on track for Q4 CY25. Project remains LTI free (lost time injury). Phase 1 grade control drilling at Mansounia commenced on 18 March 2025 …
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
GlobeNewswire
·
May 14, 2025
VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …